Search

everythinglearnresearchcommunity

for

Search:↓

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Early diagnosis and effective treatment of kerion Celsi prevent scarring and permanent hair loss.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.